JP Morgan Chase’s MediWound MDWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $61.4K | Sell |
3,971
-42
| -1% | -$731 | ﹤0.01% | 6107 |
|
|
2025
Q4 | $74.1K | Buy |
4,013
+830
| +26% | +$15.2K | ﹤0.01% | 6050 |
|
|
2025
Q3 | $57.4K | Sell |
3,183
-707
| -18% | -$13K | ﹤0.01% | 6180 |
|
|
2025
Q2 | $75.3K | Sell |
3,890
-635
| -14% | -$12K | ﹤0.01% | 5733 |
|
|
2025
Q1 | $70.2K | Buy |
4,525
+957
| +27% | +$17.1K | ﹤0.01% | 5744 |
|
|
2024
Q4 | $63.5K | Buy |
3,568
+167
| +5% | +$2.88K | ﹤0.01% | 5923 |
|
|
2024
Q3 | $61.4K | Sell |
3,401
-75,360
| -96% | -$1.38M | ﹤0.01% | 5917 |
|
|
2024
Q2 | $1.22M | Buy |
78,761
+5,424
| +7% | +$89.7K | ﹤0.01% | 4142 |
|
|
2024
Q1 | $1.05M | Buy |
73,337
+73,330
| +1,047,571% | +$1M | ﹤0.01% | 4322 |
|
|
2023
Q4 | $71 | Buy |
+7
| New | +$63 | ﹤0.01% | 7159 |
|
|
2023
Q1 | – | Sell |
-2
| Closed | – | – | 7033 |
|
|
2022
Q4 | $0 | Buy |
+2
| New | +$20 | ﹤0.01% | 6821 |
|
|
2022
Q2 | – | Sell |
-424
| Closed | -$6K | – | 6720 |
|
|
2022
Q1 | $6K | Sell |
424
-3,639
| -90% | -$59K | ﹤0.01% | 6291 |
|
|
2021
Q4 | $67K | Sell |
4,063
-8,872
| -69% | -$185K | ﹤0.01% | 5841 |
|
|
2021
Q3 | $301K | Buy |
12,935
+3,423
| +36% | +$91.4K | ﹤0.01% | 5014 |
|
|
2021
Q2 | $255K | Buy |
9,512
+3,070
| +48% | +$94.9K | ﹤0.01% | 5103 |
|
|
2021
Q1 | $242K | Buy |
+6,442
| New | +$233K | ﹤0.01% | 5071 |
|
|
2019
Q3 | – | Sell |
-5,139
| Closed | -$123K | – | 5869 |
|
|
2019
Q2 | $123K | Sell |
5,139
-7,260
| -59% | -$224K | ﹤0.01% | 4855 |
|
|
2019
Q1 | $434K | Buy |
+12,399
| New | +$417K | ﹤0.01% | 4277 |
|
|
2018
Q4 | – | Sell |
-2,349
| Closed | -$101K | – | 5825 |
|
|
2018
Q3 | $101K | Buy |
2,349
+316
| +16% | +$14.2K | ﹤0.01% | 4949 |
|
|
2018
Q2 | $98K | Buy |
2,033
+1,990
| +4,628% | +$85.7K | ﹤0.01% | 4842 |
|
|
2018
Q1 | $2K | Buy |
+43
| New | +$1.35K | ﹤0.01% | 5286 |
|
Other funds holding MDWD
IA
YLHM
RA
MIH
SFM
SBCM
